When a GLP-1 RA activates these receptors, you experience genuine loss of appetite rather than forced restriction
Study-related adverse events Adverse reactions reported in 5% of patients and occurring more frequently with Victoza compared with placebo included nausea (21.4% vs 4.4%), vomiting (12.1% vs 2.2%), diarrhea (7.1% vs 2.9%), constipation (5.7% vs 1.5%), increased lipase (15.0% vs 8.8%), GFR decreased (6.4% vs 5.1%), and headache (5.0% vs 2.9%)
Avoid sugary cocktails and mixers that spike glucose levels and trigger stronger insulin responses, which can compound medication-related blood sugar swings
Womans World spoke to a representative of the telehealth provider about how the company is combining over 60 years of weight loss experience with effective GLP-1 medication to create comprehensive weight health support
Should People With Kidney or Liver Disease Avoid Retatrutide